Dmitrij Hristodorov

555 total citations
21 papers, 451 citations indexed

About

Dmitrij Hristodorov is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Dmitrij Hristodorov has authored 21 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Dmitrij Hristodorov's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Transgenic Plants and Applications (6 papers). Dmitrij Hristodorov is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Transgenic Plants and Applications (6 papers). Dmitrij Hristodorov collaborates with scholars based in Germany, South Africa and Netherlands. Dmitrij Hristodorov's co-authors include Rainer Fischer, Stefan Barth, Radoslav Mladenov, Theo Thepen, Lars Lindén, Michael Hühn, Beate Müller‐Tiemann, Heiner Apeler, Verena von Felbert and Stefano Fiore and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Dmitrij Hristodorov

20 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitrij Hristodorov Germany 13 238 225 196 100 76 21 451
James Hunt United Kingdom 12 229 1.0× 317 1.4× 277 1.4× 121 1.2× 23 0.3× 17 662
Caroline Ekblad Sweden 12 329 1.4× 87 0.4× 308 1.6× 178 1.8× 24 0.3× 13 563
Maria-Ana Ghetie United States 14 261 1.1× 376 1.7× 330 1.7× 216 2.2× 178 2.3× 16 692
Bas van der Woning Belgium 12 272 1.1× 259 1.2× 118 0.6× 265 2.6× 19 0.3× 14 612
Shui‐on Leung United States 10 164 0.7× 131 0.6× 307 1.6× 168 1.7× 20 0.3× 28 472
Maria Liljefors Sweden 12 133 0.6× 243 1.1× 85 0.4× 224 2.2× 50 0.7× 20 451
Rens Braster Netherlands 8 202 0.8× 322 1.4× 107 0.5× 170 1.7× 13 0.2× 10 519
Cristina Mastini Italy 13 246 1.0× 275 1.2× 97 0.5× 228 2.3× 51 0.7× 15 557
Qing Tong China 13 304 1.3× 199 0.9× 94 0.5× 110 1.1× 12 0.2× 32 573
Sonia Sirlin United States 12 287 1.2× 417 1.9× 184 0.9× 71 0.7× 35 0.5× 14 668

Countries citing papers authored by Dmitrij Hristodorov

Since Specialization
Citations

This map shows the geographic impact of Dmitrij Hristodorov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitrij Hristodorov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitrij Hristodorov more than expected).

Fields of papers citing papers by Dmitrij Hristodorov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitrij Hristodorov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitrij Hristodorov. The network helps show where Dmitrij Hristodorov may publish in the future.

Co-authorship network of co-authors of Dmitrij Hristodorov

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitrij Hristodorov. A scholar is included among the top collaborators of Dmitrij Hristodorov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitrij Hristodorov. Dmitrij Hristodorov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hristodorov, Dmitrij, et al.. (2024). Investing in vision: Innovation in retinal therapeutics and the influence on venture capital investment. Progress in Retinal and Eye Research. 99. 101243–101243. 5 indexed citations
2.
Welsbie, Derek S., Hartmut Schirok, Katherine L. Mitchell, et al.. (2018). Identification of a retinal neuroprotective kinase inhibitor with preferential activity against DLK compared to LZK. 59(9). 2493–2493. 2 indexed citations
3.
Hristodorov, Dmitrij, et al.. (2017). Human MAP Tau Based Targeted Cytolytic Fusion Proteins. Biomedicines. 5(3). 36–36. 12 indexed citations
4.
Mladenov, Radoslav, Anh‐Tuan Pham, Dmitrij Hristodorov, et al.. (2016). A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein. International Journal of Cancer. 139(4). 916–927. 29 indexed citations
5.
Pham, Anh‐Tuan, Dmitrij Hristodorov, Radoslav Mladenov, et al.. (2016). Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model. Cancer Letters. 372(2). 201–209. 36 indexed citations
6.
Hristodorov, Dmitrij, Radoslav Mladenov, Rainer Fischer, Stefan Barth, & Theo Thepen. (2016). Fully human MAP‐fusion protein selectively targets and eliminates proliferating CD64+M1 macrophages. Immunology and Cell Biology. 94(5). 470–478. 14 indexed citations
7.
Mladenov, Radoslav, Dmitrij Hristodorov, Diana Klose, et al.. (2016). CD64-directed microtubule associated protein tau kills leukemic blastsex vivo. Oncotarget. 7(41). 67166–67174. 11 indexed citations
8.
Hristodorov, Dmitrij, Radoslav Mladenov, Verena von Felbert, et al.. (2015). Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies. mAbs. 7(5). 853–862. 59 indexed citations
9.
Hristodorov, Dmitrij, Radoslav Mladenov, Judith Niesen, et al.. (2015). Targeted killing of rhabdomyosarcoma cells by a MAP-based human cytolytic fusion protein. Cancer Letters. 365(2). 149–155. 10 indexed citations
10.
Mladenov, Radoslav, Dmitrij Hristodorov, Judith Niesen, et al.. (2015). The Fc‐alpha receptor is a new target antigen for immunotherapy of myeloid leukemia. International Journal of Cancer. 137(11). 2729–2738. 15 indexed citations
11.
Hristodorov, Dmitrij, Radoslav Mladenov, Judith Niesen, et al.. (2014). EpCAM-Selective Elimination of Carcinoma Cells by a Novel MAP-Based Cytolytic Fusion Protein. Molecular Cancer Therapeutics. 13(9). 2194–2202. 18 indexed citations
12.
Hristodorov, Dmitrij, et al.. (2014). Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. mAbs. 6(5). 1283–1289. 7 indexed citations
13.
14.
Schiffer, Sonja, Edgar Jost, Radoslav Mladenov, et al.. (2013). Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells. Cancer Letters. 341(2). 178–185. 23 indexed citations
15.
Schiffer, Sonja, Dmitrij Hristodorov, Radoslav Mladenov, et al.. (2013). Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages. SHILAP Revista de lepidopterología. 2(1). 9–18. 10 indexed citations
16.
Hristodorov, Dmitrij, et al.. (2013). Fighting chronic inflammation - CD64-specific elimination of M1 macrophages. Frontiers in Immunology. 4.
17.
Hristodorov, Dmitrij, Rumen Mladenov, Michael Hühn, et al.. (2013). Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo. British Journal of Cancer. 109(6). 1570–1578. 32 indexed citations
18.
Hristodorov, Dmitrij, et al.. (2012). Generation and Comparative Characterization of Glycosylated and Aglycosylated Human IgG1 Antibodies. Molecular Biotechnology. 53(3). 326–335. 58 indexed citations
19.
Hristodorov, Dmitrij, Rainer Fischer, & Lars Lindén. (2012). With or Without Sugar? (A)glycosylation of Therapeutic Antibodies. Molecular Biotechnology. 54(3). 1056–1068. 54 indexed citations
20.
Hristodorov, Dmitrij, Radoslav Mladenov, Michael Hühn, Stefan Barth, & Theo Thepen. (2012). Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases. Toxins. 4(9). 676–694. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Hunt Breakdown of academic impact, for papers by Caroline Ekblad Breakdown of academic impact, for papers by Maria-Ana Ghetie Breakdown of academic impact, for papers by Bas van der Woning Breakdown of academic impact, for papers by Shui‐on Leung Breakdown of academic impact, for papers by Maria Liljefors Breakdown of academic impact, for papers by Rens Braster Breakdown of academic impact, for papers by Cristina Mastini Breakdown of academic impact, for papers by Qing Tong Breakdown of academic impact, for papers by Sonia Sirlin
Rankless by CCL
2026